23/04/2014 13:07:54 Free Membership Login

   

Alexza

Visual Financials
Company Name: Alexza Pharmaceuticals, Inc.
Ticker Symbol: ALXA
WWW Address: http://www.alexza.com
CEO: Thomas King
No. of Employees: 63
Common Issue Type: CS
Business Description:Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 4.311 Up 0.071 4.3 4.32 4.24 4.31 4.20 53326
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 74.5 17.3 0.00 -2.38 0.00 0.0 0.0 6.65 - 3.92
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close4.24$
PE Ratio - LTM0.0
Market Capitalisation74.5mil
Latest Shares Outstanding17.3mil
Earnings pS (EPS)-2.38$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee64,603$
Effective Tax Rate0.0%
Float13.9mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.40%
Gross Profit Margin76.6%
EBITDA Margin-72.7%
Pre-Tax Profit Margin0.0%
Assets Turnover109.2%
Return on Assets (ROA)-90.4%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio2.1
Leverage Ratio (Assets/Equity)
Interest Cover-25.4
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.93$
Cash pS0.00$
Book-Value pS-1.39$
Tangible Book-Value pS-1.39$
Cash Flow pS-0.04$
Free Cash Flow pS-0.14$
KEY FIGURES (LTM): Price info
Price/Book Ratio-3.01
Price/Tangible Book Ratio0.00
Price/Cash Flow-113.6
Price/Free Cash Flow-29.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.990,007167,043
4 Weeks4.903.924.49-5.3-6128,7842,575,680
13 Weeks5.933.925.20-18.3-20125,4688,030,000
26 Weeks5.933.925.26-19.2-26113,33714,167,139
52 Weeks6.653.924.33-1.8-21221,40555,794,240
YTD5.933.92--11.3-14123,5529,390,027
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
4.184.194.884.944.870.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue1.501.80.04
Income0.0
Dividend0.0
Capital SpendingNA
R&D-16.28NA-16.16
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-61.3-61.3-28.1
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-0.91-0.913.76
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio12.08
Current Ratio1.3
Quick Ratio (Acid Test)0.9
Liquidity Ratio (Cash)1.22
Receivables Turnover0.8
Average Collection Period450
Working Capital/Equity190.4
Working Capital pS0.31
Cash-Flow pS-1.47
Free Cash-Flow pS-1.19
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-2.13
Financial Leverage Ratio (Assets/Equity)15.8
Debt Ratio93.7
Total Debt/Equity (Gearing Ratio)2.51
LT Debt/Equity0.00
LT Debt/Capital Invested748.5
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested6.53
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.78
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-3.02
Enterprise Value (EV)/Free Cash Flow-2.86
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM-3.01
Price/Cash Flow Ratio-113.6
Price/Free Cash Flow Ratio - LTM-29.0
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-16.5
5-Y Low P/E Ratio-1.1
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS1.19
Tangible Book Value pS - LTM-1.39
Book Value pS - LTM-1.39
Capital Invested pS0.15
Cash pS - LTM0.00
Cash Flow pS - LTM-0.04
Free Cash Flow pS - LTM-0.14
Earnings pS (EPS)-2.38
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-459.29
Free Cash Flow Margin 5YEAR AVG-2,708.48
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.-5.2
Equity Productivity1.58
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity1.58
Return on Capital Invested (ROCI)-1087.4
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.10
Return on Assets (ROA)-69.0
Return on Assets (ROA) - 5YEAR AVRG.-0.8
Gross Profit Margin76.6
Gross Profit Margin - 5YEAR AVRG.1.0
EBITDA Margin - LTM-72.7
EBIT Margin - LTM-79.7
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee64,603
Net Income per Employee-444,095
Average Collection Period
Receivables Turnover0.8
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales52.75
Assets/Revenue10.00
Net Working Capital Turnover0.83
Fixed Assets Turnover0.24
Total Assets Turnover0.1
Revenue per $ Cash0.23
Revenue per $ Plant0.25
Revenue per $ Common Equity1.58
Revenue per $ Capital Invested1.58
Selling, General & Adm/tive (SG&A) as % of Revenue272.6
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue536.8
R&D Expense as % of Revenue - 5YEAR AVRG.536.8

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq alxa140423 13:07